A Phase IIb, Open-Label, Randomized Controlled Dose Ranging Multi-Centre Trial to Evaluate the Safety, Tolerability, Pharmacokinetics and Exposure-Response Relationship of Different Doses of Delpazolid in Combination with Bedaquiline Delamanid Moxifloxacin in Adult Subjects with Newly Diagnosed, Uncomplicated, Smear-Positive, Drug-Sensitive Pulmonary Tuberculosis

A Dierig,M Hoelscher, S Schultz, L Hoffmann, A Jarchow-MacDonald,EM Svensson,L Te Brake,R Aarnoutse,M Boeree, TD McHugh,LM Wildner, X Gong, PPJ Phillips, LT Minja,N Ntinginya, S Mpagama, A Liyoyo,RS Wallis,M Sebe, FA Mhimbira, B Mbeya,M Rassool, L Geiter, YL Cho,N Heinrich

TRIALS（2023）

Cited 4|Views20

Key words

Uncomplicated pulmonary tuberculosis,Treatment,Delpazolid,Randomized controlled trial,Phase IIb,Oxazolidinone

AI Read Science

Must-Reading Tree

Example

Generate MRT to find the research sequence of this paper

Chat Paper

Summary is being generated by the instructions you defined